Controlled Substances Act: Schedules, Penalties & DEA Rules

The Controlled Substances Act is the 1970 federal law that governs how drugs and certain precursor chemicals are regulated in the United States. It sorts substances into five schedules based on medical usefulness, abuse potential, and dependence risk, then ties criminal penalties, prescription rules, and a DEA registration system to those classifications.¹ Everyone who legally touches a controlled substance, from the manufacturer to the pharmacist filling your prescription, operates inside that closed system.

The Five Schedules

Every controlled substance sits in one of five schedules. Three factors drive placement: whether the substance has an accepted medical use in the United States, its potential for abuse, and how likely it is to cause physical or psychological dependence.² Higher schedule number means lower perceived danger and lighter restrictions.

Schedule I is the strictest tier. These substances have a high abuse potential, no currently accepted medical use in the United States, and no accepted safe use even under medical supervision. Heroin, LSD, and marijuana (still classified here at the federal level as of 2026) are the well-known examples.

Schedule II drugs also carry high abuse potential and can cause severe dependence, but they have accepted medical uses. This tier holds potent opioids like fentanyl and oxycodone, stimulants like methamphetamine and amphetamine-based medications such as Adderall, and certain barbiturates. Schedule II prescriptions face the tightest controls of any medically available substance.

Schedule III covers substances with lower abuse potential than Schedule I or II and a moderate-to-low dependence risk. Anabolic steroids, ketamine, and products containing limited amounts of codeine (such as acetaminophen with codeine) fall here.

Schedule IV drops the abuse and dependence risk further. Benzodiazepines like alprazolam (Xanax) and diazepam (Valium) belong here, along with sleep aids like zolpidem (Ambien).

Schedule V carries the lowest restrictions and mostly contains preparations with small amounts of narcotics, such as certain cough syrups containing codeine.²

How a Drug Moves Between Schedules

The Attorney General, acting through the DEA, can add a substance to a schedule, move it between schedules, or remove it entirely. The process can start three ways: the Attorney General initiates it, the Secretary of Health and Human Services requests it, or an interested party petitions for it.³

Before formal proceedings begin, the Attorney General must ask HHS for a scientific and medical evaluation. The HHS recommendation is binding on the Attorney General regarding medical and scientific questions. If HHS recommends that a substance should not be controlled at all, the Attorney General cannot schedule it. The evaluation weighs eight factors, including pharmacological effects, history of abuse, public health risk, and dependence potential.

When a new drug poses an immediate public-safety threat, the Attorney General can place it in Schedule I on a temporary basis without waiting for the full HHS evaluation. Emergency scheduling requires 30 days’ notice in the Federal Register, lasts two years, and can be extended for one additional year. Those orders are not subject to judicial review.³

The Federal Analogue Act extends the same treatment to designer drugs. A substance that is substantially similar in chemical structure or pharmacological effect to a Schedule I or II drug is treated as Schedule I, provided it was intended for human consumption. Courts consider how the substance was marketed, its price compared to the drug it mimics, and whether it was diverted from legitimate channels.⁴

Marijuana’s Status

Marijuana is still Schedule I under federal law as of 2026, despite widespread state-level legalization. In August 2023, HHS recommended moving it to Schedule III. The Attorney General proposed a rule in May 2024 to carry out that reclassification, and in December 2025, President Trump issued an executive order directing the Attorney General to expedite the process. No final rule has been published, and the DEA administrative hearing on the proposal has been postponed pending an appeal. Until that process concludes, federal law treats marijuana the same as heroin for scheduling purposes.

Federal Penalties for Trafficking

Trafficking penalties depend on the schedule, the quantity, and whether anyone died or was seriously injured. The statute also escalates sharply for repeat offenders, so a small difference in drug weight can mean the difference between a few years and a mandatory decade in federal prison.

Schedule I and II, Top-Quantity Tier

The harshest penalties hit large-quantity manufacture or distribution of specific Schedule I or II drugs. Thresholds vary by substance: 1 kilogram or more of heroin, 5 kilograms of cocaine, 280 grams of crack cocaine, 400 grams of fentanyl, or 1,000 kilograms of marijuana. A first offense at this level carries a mandatory minimum of 10 years and a maximum of life, plus fines up to $10 million for an individual. If someone dies or suffers serious bodily injury from the drug, the mandatory minimum rises to 20 years.⁵

Schedule I and II, Mid-Quantity Tier

A second tier covers roughly one-tenth of the top-tier quantities: 100 grams of heroin, 500 grams of cocaine, or 28 grams of crack cocaine. That triggers a 5-year mandatory minimum, a 40-year maximum, and fines up to $5 million for an individual. A prior serious drug felony or violent felony conviction raises the mandatory minimum to 10 years.

Schedule I and II, Below the Thresholds

When a Schedule I or II case involves amounts below the mid-tier thresholds, there is no mandatory minimum on a first offense, but the maximum is 20 years and the individual fine can reach $1 million. Death or serious injury pushes the sentence to a mandatory 20 years up to life. A prior drug felony raises the maximum to 30 years.⁵

Small-Quantity Marijuana and Lower Schedules

Trafficking less than 50 kilograms of marijuana (or fewer than 50 plants) carries up to 5 years and a fine up to $250,000 on a first offense. A prior drug felony doubles the maximum to 10 years and $500,000.

For Schedule III, the maximum is 10 years and a $500,000 fine on a first offense, rising to 15 years if death or serious injury results. Schedule IV carries up to 5 years and a $250,000 fine. Schedule V carries up to 1 year and a $100,000 fine. A prior drug felony conviction roughly doubles the maximum prison term and fine at every level.⁵

Penalties for Simple Possession

Federal simple-possession penalties escalate with each conviction, regardless of schedule. A first offense carries up to 1 year and a minimum $1,000 fine. A second offense carries 15 days to 2 years and a minimum $2,500 fine. A third or subsequent offense carries 90 days to 3 years and a minimum $5,000 fine. Prior state drug convictions count toward this escalation, not just federal ones.⁶

Prescription Rules Patients Feel

Schedule II prescriptions cannot be refilled. If you need a continuing supply, your doctor writes a new prescription each time. Federal regulations do let a practitioner issue multiple prescriptions at once covering up to a 90-day supply, each dated to be filled on a specific future date, but only if the prescriber decides it does not create an undue risk of diversion.⁷

Schedule III and IV prescriptions may be refilled up to five times within six months of the date written. After that, you need a new prescription. Schedule V substances may be dispensed without a prescription in some cases, though distribution still has to be for a medical purpose, and state laws often add restrictions like pharmacist consultation or purchase-quantity limits.⁸

Every controlled substance prescription must be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. A prescription written outside those boundaries is not legally a prescription under the CSA at all. The regulation places a “corresponding responsibility” on the pharmacist. A pharmacist who knowingly fills a prescription that was not issued for a legitimate medical purpose faces the same penalties as the doctor who wrote it, which is why pharmacists are expected to refuse prescriptions that raise red flags like unusual quantities, high-risk combinations, or patients traveling long distances to fill them.⁹

DEA Registration for People Who Handle These Drugs

Anyone who legally manufactures, distributes, dispenses, prescribes, or researches controlled substances must hold a DEA registration. That includes manufacturers, distributors, pharmacies, physicians, nurse practitioners, veterinarians, and researchers. It is separate from any state professional license or controlled substance permit; you need both to operate legally.

Manufacturers and distributors renew annually.¹⁰ Practitioners who dispense controlled substances are registered for periods between one and three years set by DEA regulation. A renewal submitted before the expiration date lets you keep operating while it is processed. Miss the expiration and the DEA allows a one-month grace period; after that, you have to apply for an entirely new registration.

Registrants also have to keep accurate records of controlled substance transactions and make them available for DEA inspection for at least two years. A complete inventory is required when operations begin, then every two years after that.¹¹

Civil Penalties and Losing a Registration

Not every CSA violation becomes a criminal case. The DEA also imposes civil fines and administrative sanctions on registrants who break regulatory rules. Failing to keep accurate records, refusing an inspection, or distributing outside the scope of a registration can trigger civil fines without criminal prosecution.¹²

Maximums are adjusted for inflation. As of the adjustment effective July 2025, general regulatory violations (improper distribution, labeling, or security failures) run up to $82,950 per violation. Recordkeeping and reporting failures run up to $19,246 per violation. Opioid-related compliance failures by manufacturers or distributors run up to $624,123 per violation. Maintaining a drug-involved premises runs up to $459,687. These figures are per violation, so a pattern of poor recordkeeping across dozens of transactions adds up quickly.¹³

When the DEA believes a registrant’s conduct warrants suspension or revocation, it issues an Order to Show Cause. The registrant gets at least 30 days’ notice with a written summary of the allegations, then has 30 days to request a hearing before an administrative law judge. Any allegation the registrant fails to specifically deny in the response is treated as admitted.¹⁴ Losing the registration effectively ends a practitioner’s ability to prescribe controlled substances, which for many physicians, pharmacists, and researchers ends the career. The administrative process moves faster than a criminal case and carries its own severe consequences.

1
Office of the Law Revision Counsel. 21 USC Ch. 13 – Drug Abuse Prevention and Control
2
Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances
3
Office of the Law Revision Counsel. 21 USC 811 – Authority and Criteria for Classification of Substances
4
Office of the Law Revision Counsel. 21 USC 813 – Treatment of Controlled Substance Analogues
5
Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts A
6
Office of the Law Revision Counsel. 21 USC 844 – Penalties for Simple Possession
7
eCFR. 21 CFR 1306.12 – Refilling Prescriptions; Issuance of Multiple Prescriptions
8
Office of the Law Revision Counsel. 21 USC 829 – Prescriptions
9
eCFR. 21 CFR 1306.04 – Purpose of Issue of Prescription
10
Office of the Law Revision Counsel. 21 USC 822 – Persons Required to Register
11
eCFR. 21 CFR 1304.11 – Inventory Requirements
12
Office of the Law Revision Counsel. 21 USC 842 – Prohibited Acts B
13
eCFR. 28 CFR Part 85 – Civil Monetary Penalties Inflation Adjustment
14
eCFR. 21 CFR 1301.37 – Order to Show Cause